We are live on ! Find out more
TELO icon

Telomir Pharmaceuticals
TELO

27 hedge funds and large institutions have $2.91M invested in Telomir Pharmaceuticals in 2026 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 3

0.13% less ownership

Funds ownership: 6.65% → 6.52% (-0.13%)

4% less capital invested

Capital invested by funds: $3.04M → $2.91M (-$127K)

18% less funds holding

Funds holding: 33 → 27 (-6)

50% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 10

Holders
27
Holders Change
-6
Holders Change %
-18.18%
% of All Funds
0.33%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
5
Reduced
3
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Geode Capital Management
Geode Capital Management
Massachusetts
+$32.6K
2
Goldman Sachs
Goldman Sachs
New York
+$13.3K
3
PWM
Praetorian Wealth Management
California
+$12.8K
4
BlackRock
BlackRock
New York
+$4.78K
5
Osaic Holdings
Osaic Holdings
Arizona
+$2.55K

Top Sellers

1
Millennium Management
Millennium Management
New York
-$48.4K
2
VF
Virtu Financial
New York
-$19K
3
Jane Street
Jane Street
New York
-$15.5K
4
Mariner
Mariner
Kansas
-$15.5K
5
TSS
Two Sigma Securities
New York
-$13.3K
Name Holding Trade Value Shares
Change 		Change in
Stake
VCM
1
Vanguard Capital Management
Pennsylvania
$1.29M +$1.27M +995,373 New
BlackRock
2
BlackRock
New York
$376K +$4.78K +3,744 +1%
Geode Capital Management
3
Geode Capital Management
Massachusetts
$324K +$32.6K +25,537 +11%
VFT
4
Vanguard Fiduciary Trust
Pennsylvania
$176K +$173K +135,541 New
Millennium Management
5
Millennium Management
New York
$168K -$48.4K -37,915 -23%
State Street
6
State Street
Massachusetts
$76.2K – – –
Bank of New York Mellon
7
Bank of New York Mellon
New York
$66.9K – – –
SEM
8
Suncoast Equity Management
Florida
$66.6K – – –
Northern Trust
9
Northern Trust
Illinois
$54.4K – – –
WIA
10
World Investment Advisors
California
$48.1K +$2.04K +1,600 +5%
XT
11
XTX Topco
Cayman Islands
$46.9K -$4.66K -3,651 -9%
Osaic Holdings
12
Osaic Holdings
Arizona
$46.5K +$2.55K +2,000 +6%
OIA
13
OneDigital Investment Advisors
Kansas
$29.9K – – –
PWM
14
Praetorian Wealth Management
California
$26.6K +$12.8K +10,000 +100%
VAS
15
Vestmark Advisory Solutions
Massachusetts
$17K – – –
MCM
16
Morton Capital Management
California
$16.5K – – –
CA
17
Clearstead Advisors
Ohio
$16.3K – – –
KPWS
18
Kestra Private Wealth Services
Texas
$14.3K – – –
RFC
19
Regions Financial Corp
Alabama
$13.8K – – –
Goldman Sachs
20
Goldman Sachs
New York
$13.5K +$13.3K +10,411 New
UBS Group
21
UBS Group
Switzerland
$12K -$6.17K -4,835 -34%
VGA
22
Vanguard Global Advisers
Pennsylvania
$8.52K +$8.36K +6,552 New
Jones Financial Companies
23
Jones Financial Companies
Missouri
$750 – – –
BNP Paribas Financial Markets
24
BNP Paribas Financial Markets
France
$268 – – –
JP Morgan Chase
25
JP Morgan Chase
New York
$138 – – –
1
2

TELO Hedge Fund Activity: Q1 2026 in Review

27 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Telomir Pharmaceuticals (TELO) for Q1 2026, worth a combined $2.91M — down 4.2% from $3.04M a quarter earlier.

Sellers outnumbered buyers: 10 funds closed out of TELO and 5 opened new positions — a net loss of 5 holders — while 3 trimmed existing stakes and 5 added.

The largest buyer was Geode Capital Management, adding an estimated $32.6K. The largest seller was Millennium Management, cutting an estimated $48.4K.

  • 27 institutional investors held Telomir Pharmaceuticals (TELO) as of Q1 2026, down from 33 in Q4 2025.
  • Funds reported $2.91M of Telomir Pharmaceuticals stock for Q1 2026, down 4.2% quarter-over-quarter.
  • 5 funds opened new Telomir Pharmaceuticals positions in Q1 2026 and 10 closed out, a net change of -5 holders.
  • The largest Telomir Pharmaceuticals buyer in Q1 2026 was Geode Capital Management, an estimated $32.6K added.
  • The largest Telomir Pharmaceuticals seller in Q1 2026 was Millennium Management, an estimated $48.4K sold.

Based on aggregated 13F filings for Q1 2026.